ArticleProceedings of the National Academy of Sciences of the United States of America2019

A high-affinity human PD-1/PD-L2 complex informs avenues for small-molecule immune checkpoint drug discovery.

Shaogeng Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.